Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Enhances liquidity by raising more than $162 million of equity capital since the inception of the APE At-The-Market program.
Strengthens balance sheet by repurchasing approximately $36 million in
Investors often look for stocks with high short interest and a high cost to borrow, which could predict a potential short squeeze. New data shared by S3 Partners could signal which stocks investors are betting heavily against.
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Apple (AAPL)
Meta Platforms (META)
Amazon (AMZN)
Netflix (NFLX)
Invesco QQQ Trust (QQQ)
Adobe (ADBE)
Walt
One of the most highly anticipated movies of 2022 is set to be released Dec. 16, just in time for the holidays and the end-of-year box office push.
Here’s a look at early predictions for how much “Avatar: The Way Of Water” could gross and the stocks it could help.
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Apple (AAPL)
Moderna (MRNA)
Nvidia (NVDA)
Amazon (AMZN)
Coinbase Global (COIN)
Meta Platforms